New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA
valelopardo / Pixabay

New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA

According to a story from globenewswire.com, the company Progenic Pharmaceuticals recently reported the the U.S. Food and Drug Administration has recently approved the company's product iobenguane I 131 (AZEDRA). This…

Continue Reading New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA
Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease
nuzree / Pixabay

Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease

According to a public release from University of Texas Health Center at San Antonio on eurekalert.org, research using fruit fly tauopathy disease models has revealed a genetic "copy-paste" activity that…

Continue Reading Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease